Transdermal fentanyl versus sustained-release oral morphine in cancer pain: Preference, efficacy, and quality of life [The TTS-Fentanyl Comparative Trial Group]
Ahmedzai S, Brooks D. Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life [The TTS-Fentanyl Comparative Trial Group]. J Pain Symptom Manage 1997;13:254-61
Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain
Allan L, Hays H, Jensen NH, et al. Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain. Br Med J 2001;322:1154-8
Postoperative pain control with a new transdermal fentanyl delivery system. A multicenter trial
Miguel R, Kreitzer JM, Reinhart D, et al. Postoperative pain control with a new transdermal fentanyl delivery system. A multicenter trial. Anesthesiology 1995;83:470-7
Evaluation of long-term efficacy and safety of transdermal fentanyl in the treatment of chronic non-cancer pain
Milligan K, Lanteri-Minet M, Borchert K, et al. Evaluation of long-term efficacy and safety of transdermal fentanyl in the treatment of chronic non-cancer pain. J Pain 2001;2:197-204
Benefits of transdermal fentanyl in patients with rheumatoid arthritis or with osteoarthritis of the knee or hip: An open-label study to assess pain control
Pavelka K, Le Loet X, Bjorneboe O, et al. Benefits of transdermal fentanyl in patients with rheumatoid arthritis or with osteoarthritis of the knee or hip: an open-label study to assess pain control. Curr Med Res Opin 2004;20:1967-77